2004•Zhongguo shengwuzhipinxue zazhiRequires access

Preparation of Purified Bivalent Haemorrhagic Fever with Renal Syndrome Vaccine

Xiaohong Wang

Open publisher page 0 citations

Abstract

Objective To prepare purified bivalent haemorrhagic fever with renal syndrome(HFRS)vaccine containing virus antigens types Ⅰ and Ⅱ and improve its quality and immunogenicity.Methods Prepare bivalent HFRS vaccine by mixing the PS-6(type Ⅰ) and L99(type Ⅱ) strains cultured in primary hamster kidney cells(PHKC)at a volume ratio of 1∶1,and purify by precipitation with zinc acetate,concentration with ultrafiltration and Sepharose 4FF column chromatography.Results All the indexes of the purified bivalent HFRS vaccine were qualified in control tests in the NCL.The vaccine was qualified in potency test after storage at 37℃ for 2 weeks or at 4℃ for 3 years.The positive conversion rate of neutralizing antibody induced by the vaccine was above 85%,and only mild adverse reactions were observed in 5% of recipients.Conclusion The prepared vaccine met the (Trial)Requirements for Purified Bivalent Haemorrhagic Fever with Renal Syndome Vaccine and showed good quality and clinical effect.

About this research paper

What this paper is about

Objective To prepare purified bivalent haemorrhagic fever with renal syndrome(HFRS)vaccine containing virus antigens types Ⅰ and Ⅱ and improve its quality and immunogenicity.Methods Prepare bivalent HFRS vaccine by mixing the PS-6(type Ⅰ) and L99(type Ⅱ) strains cultured in primary hamster kidney cells(PHKC)at a volume ratio of 1∶1,and purify by precipitation with zinc acetate,concentration with ultrafiltration and Sepharose 4FF column chromatography.Results All the indexes of the purified bivalent HFRS vaccine were qualified in control tests in the NCL.The vaccine was qualified in potency test after storage at 37℃ for 2 weeks or at 4℃ for 3 years.The positive conversion rate of neutralizing antibody induced by the vaccine was above 85%,and only mild adverse reactions were observed in 5% of recipients.Conclusion The prepared vaccine met the (Trial)Requirements for Purified Bivalent Haemorrhagic Fever with Renal Syndome Vaccine and showed good quality and clinical effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To prepare purified bivalent haemorrhagic fever with renal syndrome(HFRS)vaccine containing virus antigens types Ⅰ and Ⅱ and improve its quality and immunogenicity.Methods Prepare bivalent HFRS vaccine by mixing the PS-6(type Ⅰ) and L99(type Ⅱ) strains cultured in primary hamster kidney cells(PHKC)at a volume ratio of 1∶1,and purify by precipitation with zinc acetate,concentration with ultrafiltration and Sepharose 4FF column chromatography.Results All the indexes of the purified bivalent HFRS vaccine were qualified in control tests in the NCL.The vaccine was qualified in potency test after storage at 37℃ for 2 weeks or at 4℃ for 3 years.The positive conversion rate of neutralizing antibody induced by the vaccine was above 85%,and only mild adverse reactions were observed in 5% of recipients.Conclusion The prepared vaccine met the (Trial)Requirements for Purified Bivalent Haemorrhagic Fever with Renal Syndome Vaccine and showed good quality and clinical effect.

Key concepts: Bivalent (engine), Immunogenicity, Potency, Virology, Antigen, Antibody, Inactivated vaccine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of Purified Bivalent Haemorrhagic Fever with Renal Syndrome Vaccine — Research Paper | ScholarLens